Topotecan and etoposide combination to test neuroblastoma in pediatric preclinical testing program.
Tonini
Gian Paolo
GP
D000951:Antigens, Neoplasm / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology* / Q000627:therapeutic use; D045744:Cell Line, Tumor; D002648:Child; D004250:DNA Topoisomerases, Type II / Q000032:analysis; D004268:DNA-Binding Proteins / Q000032:analysis; D004353:Drug Evaluation, Preclinical; D005047:Etoposide / Q000627:therapeutic use; D006801:Humans; D009447:Neuroblastoma / Q000188:drug therapy*; D019772:Topotecan / Q000627:therapeutic use
D000951:Antigens, Neoplasm; D004268:DNA-Binding Proteins; D005047:Etoposide; D019772:Topotecan; D004250:DNA Topoisomerases, Type II